Massimiliano Ria

Massimiliano Ria is a seasoned professional in pharmacovigilance and drug safety, currently serving as the Global PV Partnership and Operations Manager at Sobi - Swedish Orphan Biovitrum AB since October 2020. Ria has extensive experience across various roles, including Global Pharmacovigilance & Patient Safety Manager at TFS HealthScience and Drug Safety Manager, where responsibilities encompassed managing operational aspects of pharmacovigilance for clinical trials and post-marketing studies. Prior experience includes consulting on pharmacovigilance and compliance at ProPharma Group and serving as Local Drug Safety Officer at Bluefish Pharmaceuticals, overseeing pharmacovigilance activities across multiple countries. Ria's academic background includes a PhD in Cardiovascular Genetics from Karolinska Institutet and a Master's degree in Biology from Università degli Studi di Milano, complemented by postdoctoral research at prestigious institutions such as the University of Oxford and Karolinska Institutet.